GERMANTOWN, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology ...

Q1 2025 Earnings Call Transcript May 6, 2025 AdaptHealth Corp. reports earnings inline with expectations. Reported EPS is ...

Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ETCompany ParticipantsSuzanne Foster - CEOJason Clemens - ...

To assess a company's financial health, you have to understand its cash flow statement ... It complements the balance sheet by explaining changes in cash balances and reconciling non-cash ...

One of Australia’s most iconic TV and film actors, Gerard Kennedy, has passed away aged 93. Born on March 8, 1932 in Perth, Kennedy’s career spanned more than five decades, including his breakthrough ...

Thinking about balance sheets isn’t the most exciting part of being a small business owner. However, if you want to position your business for growth or increase your cash flow, building a fortress ...

Some drugs initially approved to treat Type 2 diabetes are now being used for cosmetic weight loss. WSJ’s Daniela Hernandez explains how they work, their side effects, and concerns over ...

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...

The once-daily pill, called orforglipron, helped patients with Type 2 diabetes during late-stage trials and has shown comparable safety results to the injectables, the drugmaker said. The trial ...

Kevin Kurz of The Athletic wondered if Briere might consider going the offer-sheet route this summer. He pointed out the Flyers GM isn't afraid to make bold moves during the off-season.

Eli Lilly’s weight loss pill orforglipron succeeded in a Phase 3 clinical trial in diabetes, helping study participants control their blood sugar while hinting at weight loss that might be comparable ...

USA: A recent 13-week clinical evaluation has demonstrated that inhaled Technosphere Insulin (TI) combined with insulin degludec offers comparable or slightly improved glycemic control in adults with ...